| |
|
|
|
Infinity Pharmaceuticals Inc.  
|
|
0.8896 0.009 (0.01%) |
07-02 11:59 |
|
Open: |
0.9088 |
Pre close: |
0.8808 |
Target:
|
1.24
|
|
High: |
0.9088 |
Low: |
0.881 |
Resistance:
|
1.06
1.18
|
|
Volume: |
17,907 |
Market Cap: |
51M |
Support:
|
0.86
0.72
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.90
 |
MACD |
MACD(12,26):
|
-0.02  |
|
MA(20): |
0.91 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.99 |
Stochastic Oscillator |
%K(14,3):
|
23.96 |
|
MA(250): |
1.13 |
%D(3): |
22.60 |
|
Average Volume(K) |
3-Month: |
16157
|
52-Week |
High:
|
1.75 |
|
10-Days: |
11895 |
Low: |
0.60 |
|
RSI |
RSI(14):
|
43.83 |
Change(%): |
-48.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.774 |
Return on Equity (ttm) |
-237.9 |
Shares Out. (M) |
57.43 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-40.2 |
Shares Float (M) |
37.91 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.51 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
-80.0 |
% Held by Institutions |
50.64 |
|
Forward EPS |
-0.830 |
Gross Profit (p.s.) |
-0.546 |
Shares Short (K) |
49 |
|
Book Value (p.s.) |
-0.040 |
EBITDA (p.s.) |
-0.732 |
P/E |
-1.14 |
|
Sales Per Share |
0.023 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-22.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-37.63 |
P/S |
38.05 |
|
Operating Margin |
-3174.61 |
Levered Free Cash Flow
(M) |
-26.72 |
P/CF |
-1.34 |
|
|
|
|
|
|
